©The Author(s) 2016.
World J Gastroenterol. Aug 7, 2016; 22(29): 6663-6672
Published online Aug 7, 2016. doi: 10.3748/wjg.v22.i29.6663
Published online Aug 7, 2016. doi: 10.3748/wjg.v22.i29.6663
Table 1 Advantages and disadvantages of liver biopsy and noninvasive models for detecting liver fibrosis
| Liver biopsy | Noninvasive models | |
| Advantages | Gold standard to assess fibrosis | Non-invasive |
| Direct observation and quantitative assessment of fibrosis, inflammation and steatosis | Inter-laboratory reproducibility | |
| Different stage by different scoring systems | High applicability and wide availability for repeated assays | |
| Diagnosing different forms of liver disease | Reasonable cost | |
| Accurately assessing progression of liver disease or the effect of therapy | Accurate assessment of cirrhosis and minimal/no fibrosis | |
| Disadvantages | Invasive | Less accurate for intermediate fibrosis stages |
| Sampling error and inter-observer differences | False positive values | |
| Unsuitable for repeated assays | Scores may change in different disease stages | |
| Risk of complications, rare major complications, morbidity and mortality | Unsuitable for diagnosing liver disease | |
| Expensive | Not quantitative |
- Citation: Zeng DW, Dong J, Liu YR, Jiang JJ, Zhu YY. Noninvasive models for assessment of liver fibrosis in patients with chronic hepatitis B virus infection. World J Gastroenterol 2016; 22(29): 6663-6672
- URL: https://www.wjgnet.com/1007-9327/full/v22/i29/6663.htm
- DOI: https://dx.doi.org/10.3748/wjg.v22.i29.6663